Tyra Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $502 | $0 |
Gross Profit | -126 | -122 | 400 | -82 |
EBITDA | -23,406 | -22,200 | -25,532 | -23,881 |
EBIT | -23,532 | -22,322 | -25,634 | -23,963 |
Net Income | -18,702 | -18,192 | -22,830 | -21,152 |
Net Change In Cash | 0 | 0 | 502 | 0 |
Free Cash Flow | -10,728 | -22,164 | -14,135 | -17,228 |
Cash | 99,490 | 254,366 | 58,006 | 215,652 |
Basic Shares | 58,668 | 52,228 | 42,965 | 42,868 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -353 | -296 | -140 | -47 |
EBITDA | -79,592 | -58,631 | -26,148 | -9,273 |
EBIT | -79,945 | -58,927 | -26,288 | -9,320 |
Net Income | -69,134 | -51,723 | -26,141 | -9,314 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -50,212 | 286,958 | ||
Free Cash Flow | -50,909 | -50,844 | -24,406 | -8,075 |
Cash | 58,006 | 251,213 | 302,182 | 15,224 |
Basic Shares | 42,704 | 41,883 | 41,441 | 42,535 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.32 |
2024-03-31 | -$0.35 |
2023-12-31 | -$0.53 |
2023-09-30 | -$0.49 |
